Class-leading device technology

Vectura has deep expertise applied to its approved devices and across its innovative pipeline spanning the complete range of inhalation delivery types. These include cost-effective DPI and pMDI devices, through to smart nebulisers optimised for targeted lung delivery of a wide range of dose levels. In particular, Vectura’s differentiated smart nebuliser technology has the potential to demonstrate significant improvement in efficacy and/or reduction in treatment time over conventional nebulisers.

Vectura's dry powder inhalers build on commercially validated platform

  • Robust and low cost
  • Simple and intuitive user interface
  • Builds on proven DPI platform
  • Enabled via add-on or integrated connectivity
  • Consistent performance across range of products
  • Broad and long dated patent coverage
devices-gyrohaler.jpg

GyroHaler®

devices-lever.jpg

Lever-operated

devices-openinhale.jpg

Open-Inhale-Close

devices-multi.jpg

Multi-use single unit dose

Vectura's pressurised metered dose inhalers are familiar and universally acceptable

  • Portable and robust
  • Synchronisation improved when combined with spacers
  • Breath actuation in partnership with Mundipharma
  • Active dispersion enables low inspiration flow rates
  • Front-facing dose indicator
  • Low cost
  • Designed for high volume manufacture
devices-doseind.jpg

Dose indicating
pMDI actuator


Vectura’s differentiated nebulised devices provide opportunity for enhanced outcomes and shorter treatment times

  • Breath actuation
  • Faster delivery
  • Potential to increase efficiency and reduce drug dosage
  • Low inspiration flow rate
  • Controlled inhalation volume
  • Potential for use in large molecules including biologics
devices-akita.jpg

AKITA® JET

devices-fox.jpg

FOX®